105 related articles for article (PubMed ID: 19383331)
1. 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
Ihrlund LS; Hernlund E; Khan O; Shoshan MC
Mol Oncol; 2008 Jun; 2(1):94-101. PubMed ID: 19383331
[TBL] [Abstract][Full Text] [Related]
2. 3-Bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective "small molecule" anti-cancer agent taken from labside to bedside: introduction to a special issue.
Pedersen PL
J Bioenerg Biomembr; 2012 Feb; 44(1):1-6. PubMed ID: 22382780
[TBL] [Abstract][Full Text] [Related]
3. Local delivery of cancer-cell glycolytic inhibitors in high-grade glioma.
Wicks RT; Azadi J; Mangraviti A; Zhang I; Hwang L; Joshi A; Bow H; Hutt-Cabezas M; Martin KL; Rudek MA; Zhao M; Brem H; Tyler BM
Neuro Oncol; 2015 Jan; 17(1):70-80. PubMed ID: 25053853
[TBL] [Abstract][Full Text] [Related]
4. Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study.
El Sayed SM; Mohamed WG; Seddik MA; Ahmed AS; Mahmoud AG; Amer WH; Helmy Nabo MM; Hamed AR; Ahmed NS; Abd-Allah AA
Chin J Cancer; 2014 Jul; 33(7):356-64. PubMed ID: 24636230
[TBL] [Abstract][Full Text] [Related]
5. 3-Bromopyruvate: targets and outcomes.
Shoshan MC
J Bioenerg Biomembr; 2012 Feb; 44(1):7-15. PubMed ID: 22298255
[TBL] [Abstract][Full Text] [Related]
6. Targets of 3-bromopyruvate, a new, energy depleting, anticancer agent.
Dell'Antone P
Med Chem; 2009 Nov; 5(6):491-6. PubMed ID: 19534685
[TBL] [Abstract][Full Text] [Related]
7. L-Glyceraldehyde Inhibits Neuroblastoma Cell Growth via a Multi-Modal Mechanism on Metabolism and Signaling.
Forbes M; Kempa R; Mastrobuoni G; Rayman L; Pietzke M; Bayram S; Arlt B; Spruessel A; Deubzer HE; Kempa S
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730615
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer.
Liao M; Yao D; Wu L; Luo C; Wang Z; Zhang J; Liu B
Acta Pharm Sin B; 2024 Mar; 14(3):953-1008. PubMed ID: 38487001
[TBL] [Abstract][Full Text] [Related]
9. Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma.
Trejo-Solis C; Silva-Adaya D; Serrano-García N; Magaña-Maldonado R; Jimenez-Farfan D; Ferreira-Guerrero E; Cruz-Salgado A; Castillo-Rodriguez RA
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139462
[TBL] [Abstract][Full Text] [Related]
10. Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly.
Chu YD; Chen CW; Lai MW; Lim SN; Lin WR
World J Gastroenterol; 2023 Aug; 29(29):4499-4527. PubMed ID: 37621758
[TBL] [Abstract][Full Text] [Related]
11. Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options.
Pourbaghi M; Haghani L; Zhao K; Karimi A; Marinelli B; Erinjeri JP; Geschwind JH; Yarmohammadi H
Curr Oncol; 2023 Jul; 30(7):6609-6622. PubMed ID: 37504345
[TBL] [Abstract][Full Text] [Related]
12. Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance.
Lei P; Wang W; Sheldon M; Sun Y; Yao F; Ma L
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444501
[TBL] [Abstract][Full Text] [Related]
13. Cardiomyocyte infection by
Venturini G; Alvim JM; Padilha K; Toepfer CN; Gorham JM; Wasson LK; Biagi D; Schenkman S; Carvalho VM; Salgueiro JS; Cardozo KHM; Krieger JE; Pereira AC; Seidman JG; Seidman CE
Front Cell Infect Microbiol; 2023; 13():1098457. PubMed ID: 36814444
[TBL] [Abstract][Full Text] [Related]
14. Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies.
Zhang Y; Li Q; Huang Z; Li B; Nice EC; Huang C; Wei L; Zou B
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230492
[TBL] [Abstract][Full Text] [Related]
15. The combined effect of dichloroacetate and 3-bromopyruvate on glucose metabolism in colorectal cancer cell line, HT-29; the mitochondrial pathway apoptosis.
Nikravesh H; Khodayar MJ; Behmanesh B; Mahdavinia M; Teimoori A; Alboghobeish S; Zeidooni L
BMC Cancer; 2021 Aug; 21(1):903. PubMed ID: 34364387
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial Function Are Disturbed in the Presence of the Anticancer Drug, 3-Bromopyruvate.
Cal M; Matyjaszczyk I; Filik K; Ogórek R; Ko Y; Ułaszewski S
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205737
[TBL] [Abstract][Full Text] [Related]
17. Development and Evaluation of Paclitaxel and Curcumin Dry Powder for Inhalation Lung Cancer Treatment.
Lee WH; Loo CY; Traini D; Young PM
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33375181
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells.
Petricciuolo M; Davidescu M; Fettucciari K; Gatticchi L; Brancorsini S; Roberti R; Corazzi L; Macchioni L
Heliyon; 2020 Dec; 6(12):e05741. PubMed ID: 33364504
[TBL] [Abstract][Full Text] [Related]
19. Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy.
Fendt SM; Frezza C; Erez A
Cancer Discov; 2020 Dec; 10(12):1797-1807. PubMed ID: 33139243
[TBL] [Abstract][Full Text] [Related]
20. Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.
Li J; Eu JQ; Kong LR; Wang L; Lim YC; Goh BC; Wong ALA
Molecules; 2020 Oct; 25(20):. PubMed ID: 33092283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
